Offers a basis in synthetic and physical organic chemistry. This guide highlights strategies for aggressive drug development programs, green synthesis processes, and other trends in the industry. It illustrates the impact of non-traditional small molecules as a therapeutic agent, including case studies on agents such as inhibitors and antagonists.

The second installment of Process Chemistry in the Pharmaceutical Industry enhances coverage of regulatory issues, crystallization, new technologies, automation, outsourcing, and future trends. Readers will gain insight into the multi-faceted challenges that process scientists face in tackling synthetic tasks under a regulatory framework. This book explains safety methods and design experiments while also analyzing time-to-market schedules and the consequences of accelerating the development process. Clarifying the misinterpretation of process chemistry as mere scale-up work, this text also...